Development, validation, and proof-of-concept implementation of a two-year risk prediction model for undiagnosed atrial fibrillation using common electronic health data (UNAFIED)

Autor: Sarah A. El-Azab, Francis Pike, Siu L. Hui, Timothy D. Imler, Jarod Baker, Sands George Harry, Mohammad Ateya, Randall W. Grout

Publikováno v: BMC Medical Informatics and Decision Making
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-9 (2021)

Background Many patients with atrial fibrillation (AF) remain undiagnosed despite availability of interventions to reduce stroke risk. Predictive models to date are limited by data requirements and theoretical usage. We aimed to develop a model for p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4436c1988aab07367abee77952e3bac
http://europepmc.org/articles/PMC8019173

The efficacy of continuous versus intermittent celecoxib treatment in osteoarthritis patients aged <60 and ≥60 years

Autor: Margaret Noyes Essex, Sands George Harry, Pritha Bhadra Brown

Publikováno v: International Journal of Clinical Rheumatology. 9:13-20

Aim: To characterize the effect of age on the efficacy of continuous versus intermittent celecoxib treatment. Materials & methods: Prespecified exploratory analysis of a double-blind, parallel-group, randomized, multicenter international study. A tot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a160a2a07cedff70cc73b5f86cbe9663
https://doi.org/10.2217/ijr.13.71

Healthcare resource utilization and economic impact of a ≥2 g/dL decrease in hemoglobin in osteoarthritis patients

Autor: Joseph C. Cappelleri, Jay L. Goldstein, Xuemei Luo, Sands George Harry

Publikováno v: Journal of Medical Economics. 16:430-439

In non-steroidal anti-inflammatory drug (NSAID) users, chronic occult blood loss may lead to decreases in hemoglobin, which may lead to increased healthcare expenditures. This study, therefore, sought to quantify healthcare resource utilization of �

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f73b6c31f72a5a9823e578ce49742e4
https://doi.org/10.3111/13696998.2013.768529

Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)

Autor: James M. Scheiman, David A. Peura, Francis K.L. Chan, C. Li, Charles M. Wilcox, Jay L. Goldstein, Angel Lanas, Sands George Harry

Publikováno v: Alimentary Pharmacology & Therapeutics. 36:485-492

Nonsteroidal anti-inflammatory drugs are associated with gastrointestinal (GI) damage. The Celecoxib vs. Omeprazole and Diclofenac for At-Risk Osteoarthritis and Rheumatoid Arthritis Patients (CONDOR) trial showed that a haemoglobin drop ≥2 g/dL ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531dd47421ebc80e76db5974aa708aa0
https://doi.org/10.1111/j.1365-2036.2012.05213.x

Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials

Autor: H. Nguyen, Angel Lanas, Charles M. Wilcox, David A. Peura, Jay L. Goldstein, Sands George Harry, Manuela F. Berger, James M. Scheiman, Francis K.L. Chan

Publikováno v: Alimentary Pharmacology & Therapeutics. 34:808-816

Aliment Pharmacol Ther 2011; 34: 808–816 Summary Background Nonsteroidal anti-inflammatory drugs (NSAIDs) have been associated with clinically significant decreases in haemoglobin dependent and independent of acute bleeding events. Aim To evaluate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::56bd5fc5230fc5a08fa1889fc6d658eb
https://doi.org/10.1111/j.1365-2036.2011.04790.x